Worldwide News

T-Cypher Bio, a biotech company pioneering a novel approach to (T cell receptor) TCR therapeutics has separated from Orbit Discovery to focus on developing a functional, high-throughput, bead-display platform to select therapeutically relevant targets and identify potent, target-specific TCRs for the treatment of solid tumours and other indications. The formation of T-Cypher has been financed […]

Patricia Ahrweiler, Field Marketing Manager, Gyros Protein Technologies explains how its Gyrolab Bioaffy 4000 CD extends Gyrolab assay sensitivity to the low picogram level for improved analysis of biomarkers Biomarker research has accelerated in recent years, driving the development of novel biomarker candidates and panels for the study of a range of diseases. A case in […]

Professor Sarah Gilbert, head of the team behind the Oxford AstraZeneca COVID-19 vaccine, has told UK MPs that there is a possibility the vaccine could be taken orally and perhaps also via a nasal spray. Reported in The Guardian newspaper today, she was asked by MP Graham Stringer how the vaccine might be developed in […]

A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in Nature Communications. The study titled Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits highlights a vital piece of information creating a […]

ELRIG’s virtual event  will take place on 23 and 24 February and will cover therapeutic innovation for the new decade. Research and Innovation 2021 will delve into the following four key scientific areas: Innovations in structural biology & biophysics; The rise of immunology across drug discovery; Seeking novel drug targets for the discovery pipeline, and Innovative medicines: novel antimicrobials […]

The Cell and Gene Therapy Catapult (CGT Catapult) has published today the 2020 Advanced Therapy Medicinal Product (ATMP) clinical trials database and report, which show a marked 20% growth in the number of ATMP clinical trials across the UK. The number of commercially sponsored trials has shown a dramatic surge since 2019, with an almost […]

Mark Egerton, Chief Executive Officer, Quotient Sciences, spoke to Lu Rahman about the company’s acquisition of Arcinova and what it means for the drug discovery sector. Quotient Sciences, the drug development and manufacturing accelerator, recently acquired Arcinova, the UK-based multiservice contract development and manufacturing organisation (CDMO). Boasting over 40 years of experience and 160 employees, Arcinova […]

ERS Genomics and G+FLAS Life Sciences, a biotechnology company developing research tools and reagents associated with CRISPR technology, have announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio. G+FLAS supports research organisations by providing CRISPR-related biological research services, tools, and reagents. The Ccampany produces all research tools and reagents under […]

The European Medicines Agency (EMA) has published IDMP data standardsthat will drive change and innovation in the life sciences sector. Remco Munnik, Associate Director at Life Sciences consultancy, Iperion, has been working with the group creating the EU IDMP Implementation Guide version 2.0 (EU IG). Iperion will revealthe implications of the data standards for the […]

The study is the first to describe across an entire country the effect of the Pfizer and Oxford-AstraZeneca jabs in the community on preventing severe illness resulting in hospitalisation. Previous results about vaccine efficacy have come from clinical trials. Hospitalisation drop By the fourth week after receiving the initial dose, the Pfizer and Oxford-AstraZeneca vaccines […]